Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors (2020)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.1371/journal.pone.0242405
- Subjects: TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE; FARMACOTERAPIA; PEDIATRIA; HIV; CRIANÇAS
- Keywords: Antiretroviral therapy; Protease inhibitor therapy; Drug therapy; Protease inhibitors; Pediatrics; Reverse transcriptase inhibitors; Questionnaires; Drug adherence
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2020
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
YIN, Dwight E. et al. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, v. 15, n. 11, p. 1-18, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0242405. Acesso em: 06 out. 2024. -
APA
Yin, D. E., Ludema, C., Cole, S. R., Golin, C. E., Miller, W. C., Warshaw, M. G., et al. (2020). Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, 15( 11), 1-18. doi:10.1371/journal.pone.0242405 -
NLM
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2024 out. 06 ] Available from: https://doi.org/10.1371/journal.pone.0242405 -
Vancouver
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2024 out. 06 ] Available from: https://doi.org/10.1371/journal.pone.0242405 - Hiv-i iga antibodies in the diagnosis of hiv infection in infants
- Lues congenita: o desafio do manejo de recem-nascidos de maes soropositivas no parto
- Lues congenita: o desafio do manejo de recem-nascidos de maes soropositivas
- A criança com indícios de infecção congênita: frequência de confirmação diagnóstica e dos diversos agentes envolvidos
- Infecções neonatais hospitalares
- Imunogenicidade da vacina contra hepatite B iniciada precocemente em pré-termos: implicações para a prevenção
- Maternal antiretroviral exposure during pregnancy and infant hematological and liver enzyme abnormalities
- Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NIDSI perinatal study
- Laboratory-based surveillance of streptococcus pneumoniae invasive disease (IPD) in children: serotype distribution and estimation of vaccines coverage
- Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean
Informações sobre o DOI: 10.1371/journal.pone.0242405 (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
003048359.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas